BriaCell closes $5M offering of 5.1M shares and warrants at $0.975/unit

BriaCell Therapeutics Corp.

5,128,500 common shares and warrants to purchase 5,128,500 common shares sold at $0.975 per unit.
Gross proceeds ~$5M; warrants exercisable at $0.85/share for five years from issuance.
Proceeds for working capital, general corporate purposes, and business advancement.
ThinkEquity acted as sole placement agent; placement agent warrants issued.
Offering closed October 2, 2024, under effective shelf registration statement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.